Research Isn’t Abstract Science But a Pathway to Answers, Treatments, and Hope – ASH
American Society of Hematology shared a post on LinkedIn:
“On Rare Disease Day, let’s remember that research isn’t abstract science but a pathway to answers, treatments, and hope.
For people living with rare blood disorders, every new study, discovery, and clinical trial brings us closer to better diagnostics, safer therapies, and improved quality of life.
The ASH Research Awards Fund supports innovative research that can transform care for rare blood diseases—from early-stage ideas to breakthrough treatments.
When you give, you’re directly fueling the work that patients and families are counting on.
Your support helps to:
- Advance promising research in rare blood disorders
- Accelerate the development of new treatment options
- Bring hope to patients and families worldwide
Together, we can turn rare disease research into real-world impact for the people who need it most.”
Other posts about American Society of Hematology on Hemostasis Today.
-
Mar 3, 2026, 14:46Jessica Nolan: Exploring Religious Coping in Stroke Survivors
-
Mar 3, 2026, 14:42Mervyn Morgan: Attending the Rare Haematology and Blood Disorders Cohort Meeting
-
Mar 3, 2026, 14:36Elsayed S. Moubarak: Evaluating Established and Emerging Biomarkers in Hemophilia A and B Management
-
Mar 3, 2026, 14:28Stephanie Matz: Recognizing the Incredible Social Work Team at Hemophilia of Georgia
-
Mar 3, 2026, 14:21Danny Hsu: The 2nd THANZ Webinar Series To Bring Timely Updates in Thrombosis and Hemostasis
-
Mar 3, 2026, 14:10Kalyan Roy: Understanding Erythroblastosis Fetalis
-
Mar 3, 2026, 14:04Najah Sampson: Understanding Key Risk Factors and Symptoms of VTE
-
Mar 3, 2026, 09:10From Fear to Freedom: Hemophilia A, Emicizumab Prophylaxis, and the Rewriting of a Childhood
-
Mar 3, 2026, 09:01Amy Owen-Wyard: A Life Should Not Have a Price Tag Attached to Its Rarity